Bluebird Bio - 48 Year Dividend Yield History | BLUE

Historical dividend payout and yield for Bluebird Bio (BLUE) since 1971. The current TTM dividend payout for Bluebird Bio (BLUE) as of February 22, 2019 is $0.00. The current dividend yield for Bluebird Bio as of February 22, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $7.298B $0.035B
Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.316B 12.97
Gilead Sciences (GILD) United States $86.647B 10.87
Bio-Techne Corp (TECH) United States $7.316B 49.29